Longitudinal Changes of Bone Mineral Density and Metabolism in Antiretroviral-Treated Human Immunodeficiency Virus-Infected Children

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 1, 2004, Pages 24-28

  Mora, Stefano ^a,c   Zamproni, Ilaria ^a   Beccio, Sabrina ^b   Bianchi, Roberta ^b   Giacomet, Vania ^b   Viganò, Alessandra ^b  

^a Istituto Scientifico Universitario San Raffaele   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Laboratory of Pediatric Endocrinology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; AGE; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; LONGITUDINAL STUDY; LUMBAR SPINE; MALE; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; URINALYSIS;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; BONE RESORPTION; CHILD; CHILD, PRESCHOOL; COLLAGEN; COLLAGEN TYPE I; DENSITOMETRY, X-RAY; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; MALE; PEPTIDES;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0842313032     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030767     Document Type: Article

References (35)

1. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853-860
2. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA 1998 A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51-F58
3. Miller KD, Cameron M, Wood LV, Dalakas MC, Kovacs JA 2000 Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med 133:192-196
4. Chariot P, Drogou I, de Lacroix-Szamania I, Eliezer-Vanerot MC, Chazaud B, Lombes A, Schaeffer A, Zafrani ES 1999 Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J Hepatol 30:156-160
5. Tebas F, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE 2000 Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:F63-F67
6. Teichmann J, Stephan E, Discher T, Lange U, Federlin K, Stracke H, Friese G, Lohmeyer J, Bretzel RG 2000 Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human deficiency virus infection. Metabolism 49:1134-1139
7. Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK 2001 Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab 86:2020-2026
8. Carr A, Miller J, Eisman JA, Cooper DA 2001 Osteopenia in HIV-infected men: association with asymptomatic lactic acid acidemia and lower weight pre-antiretroviral therapy. AIDS 15:703-709
9. Loiseau-Pérčs S, Delaunay C, Poupon S, Lespessailles E, Ballouche N, Arsac P, Benhamou CL 2002 Osteopenia in patients infected by the human immunodeficiency virus. A case control study. Joint Bone Spine 69:482-485
10. Knobel H, Guelar A, Valdecillo G, Nogues X, Diez A 2001 Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 15:807-808
11. Fessel WJ, Hurley LB 2003 Is HIV sequestered in bone? Possible implications of virological and immunological findings in some HIV-infected patients with bone disease. AIDS 17:255-257
12. O'Brien KO, Razavi M, Henderson RA, Caballero B, Ellis KJ 2001 Bone mineral content in girls perinatally infected with HIV. Am J Clin Nutr 73: 821-826
13. Mora S, Sala N, Bricalli D, Zuin G, Chiumello G, Viganò A 2001 Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy. AIDS 15:1823-1829
14. Tan MB, Nelson RP, James-Yarish M, Emmanuel PJ, Schurman SJ 2001 Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor. J Pediatr 139:447-451
15. Arpadi SM, Horlick M, Thorton J, Cuff PA, Wang J, Kotler DP 2002 Bone mineral content is lower in prepubertal HIV-infected children. J Acquir Immune Defic Syndr 29:450-454
16. Bachrach L 2001 Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 12:22-28
17. Mora S, Gilsanz V 2003 Establishment of peak bone mass. Endocrinol Metab Clin North Am 32:39-63
18. Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, Parfitt AM 2000 Normative data for iliac bone histomorphometry in growing children. Bone 26:103-109
19. Seibel MJ 2003 Biochemical markers of bone remodeling. Endocrinol Metab Clin North Am 32:83-113
20. Blumsohn A, Hannon RA, Wrate R, Barton J, al-Dehaimi AW, Colwell A, Eastell R 1994 Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol (Oxf) 40:663-670
21. Mora S, Prinster C, Proverbio MC, Bellini A, de Poli SC, Weber G, Abbiati G, Chiumello G 1998 Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty. Calcif Tissue Int 63:369-374
22. Mora S, Pisitukcheewanont P, Kaufman FR, Nelson JC, Gilsanz V 1999 Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res 14: 1664-1671
23. Paton NIJ, Macallan DC, Griffin GE, Pazianas M 1997 Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 61:30-32
24. Nolan D, Upton R, McKinnon E, John M, James I, Adler B, Roff G, Vasikaran S, Mallal S 2001 Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS 15:1275-1280
25. Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P 2003 Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 36:482-490
26. Cacciari E, Milani S, Balsamo A, Dammacco F, De Luca F, Chiarelli F, Pasquino AM, Tonini G, Vanelli M 2002 Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr 56:171-180
27. Tanner JM, Whitehouse RH 1976 Clinical longitudinal standards for height, weight, height velocity and weight velocity and stages of puberty. Arch Dis Child 51:170-179
28. Viganò A, Mora S, Testolin C, Beccio S, Schneider L, Bricalli D, Vanzulli A, Manzoni P, Brambilla P 2003 Increased lipodystrophy is associated with increased exposure to highly active antirerroviral therapy in HIV-infected children. J Acquir Immune Defic Syndr 32:482-489
29. Njeh CF, Samat SB, Nightingale A, McNeil EA, Boivin CM 1997 Radiation dose and in vitro precision in paediatric bone mineral density measurement using dual X-ray absorptiometry. Br J Radiol 70:719-727
30. Mora S, Barera G, Beccio S, Menni L, Proverbio MC, Bianchi C, Chiumello G 2001 A prospective, longitudinal study of the long-term effect of treatment on bone density in children with celiac disease. J Pediatr 139:516-521
31. Gilsanz V 1998 Bone density in children: a review of the available techniques and indications. Eur J Radiol 26:177-182
32. Mora S, Gilsanz V 1998 Bone densitometry in children. In: Genant HK, Guglielmi G, Jercas M, eds. Bone densitometry and osteoporosis. Berlin: Springer; 489-501
33. Prentice A, Parsons TJ, Cole TJ 1994 Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr 60:837-842
34. Aukrust P, Haug CJ, Ueland T, Lien E, Müller F, Espevik T, Bollerslev J, Frøland SS 1999 Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy. J Clin Endocrinol Metab 84:145-150
35. Khosla S, Kleerekoper M 1999 Biochemical markers of bone turnover. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott Williams, Wilkins; 128-134